Back to News
Market Impact: 0.1
Sensei Biotherapeutics, Inc. Reports Third Quarter 2026 Financial Results
Source: Nasdaq
Corporate EarningsCompany Fundamentals
Faeth Therapeutics (formerly Sensei Biotherapeutics) reported $174.8 million in cash, cash equivalents and marketable securities as of September 30, 2026. The article text is truncated after beginning a comparison with $21.2 million, so the comparison period and the rest of the quarterly results are unavailable.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- ‘Lawyer up’: Democrats take the House, and warn Trump’s family businesses are first in line for subpoenas